 Marsha Guess
Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Organ Prolapse | 14 | 2026 | 62 | 3.390 |
Why?
| | Pelvic Floor | 5 | 2026 | 32 | 1.480 |
Why?
| | Urinary Incontinence | 4 | 2019 | 65 | 1.420 |
Why?
| | Bicycling | 4 | 2014 | 117 | 1.270 |
Why?
| | Genitalia, Female | 6 | 2017 | 42 | 1.140 |
Why?
| | Sexual Dysfunction, Physiological | 5 | 2017 | 75 | 1.060 |
Why?
| | Ligaments | 8 | 2026 | 76 | 0.950 |
Why?
| | Postpartum Period | 2 | 2019 | 372 | 0.850 |
Why?
| | Obstetrics | 1 | 2026 | 177 | 0.820 |
Why?
| | Gynecology | 1 | 2026 | 181 | 0.810 |
Why?
| | Pelvic Floor Disorders | 3 | 2022 | 16 | 0.800 |
Why?
| | Vibration | 4 | 2017 | 70 | 0.660 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2019 | 1415 | 0.560 |
Why?
| | Uterus | 7 | 2026 | 226 | 0.560 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2019 | 61 | 0.560 |
Why?
| | Constipation | 1 | 2019 | 98 | 0.550 |
Why?
| | Vagina | 6 | 2026 | 202 | 0.540 |
Why?
| | Physical Examination | 1 | 2019 | 243 | 0.540 |
Why?
| | Health Services Accessibility | 1 | 2026 | 1099 | 0.530 |
Why?
| | Electric Stimulation Therapy | 1 | 2017 | 62 | 0.500 |
Why?
| | Puerperal Disorders | 1 | 2013 | 36 | 0.380 |
Why?
| | Sacrum | 5 | 2026 | 77 | 0.360 |
Why?
| | Fecal Incontinence | 3 | 2022 | 90 | 0.360 |
Why?
| | Body Mass Index | 3 | 2015 | 2437 | 0.350 |
Why?
| | Sensation | 3 | 2012 | 55 | 0.340 |
Why?
| | Cross-Sectional Studies | 7 | 2026 | 5886 | 0.340 |
Why?
| | Surgery, Plastic | 1 | 2012 | 53 | 0.340 |
Why?
| | Adult | 20 | 2026 | 40665 | 0.300 |
Why?
| | Female | 35 | 2026 | 78636 | 0.300 |
Why?
| | Pregnancy | 4 | 2019 | 7182 | 0.290 |
Why?
| | Recovery of Function | 1 | 2013 | 715 | 0.290 |
Why?
| | Clitoris | 2 | 2006 | 9 | 0.260 |
Why?
| | Surveys and Questionnaires | 6 | 2026 | 6055 | 0.240 |
Why?
| | Middle Aged | 17 | 2026 | 36126 | 0.240 |
Why?
| | Elastin | 1 | 2026 | 78 | 0.230 |
Why?
| | Young Adult | 7 | 2024 | 14176 | 0.230 |
Why?
| | Homeodomain Proteins | 4 | 2012 | 522 | 0.230 |
Why?
| | Humans | 36 | 2026 | 145140 | 0.220 |
Why?
| | Cell-Penetrating Peptides | 1 | 2025 | 21 | 0.220 |
Why?
| | Gentamicins | 1 | 2025 | 50 | 0.220 |
Why?
| | Hysterectomy | 4 | 2024 | 138 | 0.210 |
Why?
| | Sexual Behavior | 3 | 2017 | 494 | 0.210 |
Why?
| | Gynecologic Surgical Procedures | 1 | 2024 | 67 | 0.210 |
Why?
| | Consensus | 3 | 2022 | 478 | 0.200 |
Why?
| | Running | 1 | 2006 | 230 | 0.200 |
Why?
| | Pseudomonas Infections | 1 | 2025 | 230 | 0.190 |
Why?
| | Mast Cells | 1 | 2024 | 147 | 0.190 |
Why?
| | Urinary Tract Infections | 1 | 2025 | 210 | 0.180 |
Why?
| | Perineum | 2 | 2012 | 37 | 0.180 |
Why?
| | Suburethral Slings | 2 | 2013 | 10 | 0.170 |
Why?
| | Pelvis | 2 | 2016 | 125 | 0.170 |
Why?
| | Drug Delivery Systems | 1 | 2025 | 380 | 0.170 |
Why?
| | Delivery, Obstetric | 3 | 2015 | 160 | 0.170 |
Why?
| | Equipment Design | 2 | 2014 | 525 | 0.170 |
Why?
| | Uterine Prolapse | 4 | 2009 | 14 | 0.170 |
Why?
| | Pain Management | 1 | 2024 | 409 | 0.160 |
Why?
| | Receptors, Estrogen | 1 | 2023 | 401 | 0.160 |
Why?
| | Cesarean Section | 3 | 2013 | 229 | 0.160 |
Why?
| | Sexual Dysfunctions, Psychological | 3 | 2012 | 30 | 0.160 |
Why?
| | Pelvic Pain | 1 | 2019 | 42 | 0.140 |
Why?
| | Radiology | 1 | 2021 | 174 | 0.140 |
Why?
| | Orgasm | 1 | 2017 | 6 | 0.130 |
Why?
| | Health Surveys | 1 | 2019 | 517 | 0.130 |
Why?
| | Models, Animal | 2 | 2016 | 393 | 0.120 |
Why?
| | Biopsy | 2 | 2026 | 1079 | 0.120 |
Why?
| | Logistic Models | 2 | 2019 | 2133 | 0.120 |
Why?
| | Prospective Studies | 4 | 2020 | 8035 | 0.120 |
Why?
| | Connecticut | 1 | 2015 | 25 | 0.120 |
Why?
| | Surgical Mesh | 2 | 2013 | 50 | 0.110 |
Why?
| | Risk Factors | 4 | 2020 | 10857 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1922 | 0.100 |
Why?
| | Trial of Labor | 1 | 2013 | 18 | 0.100 |
Why?
| | Urinary Incontinence, Stress | 1 | 2013 | 15 | 0.100 |
Why?
| | Women's Health | 2 | 2006 | 314 | 0.100 |
Why?
| | Libido | 1 | 2012 | 24 | 0.090 |
Why?
| | China | 1 | 2013 | 269 | 0.090 |
Why?
| | Adolescent | 3 | 2024 | 22479 | 0.090 |
Why?
| | Aged | 7 | 2024 | 26096 | 0.090 |
Why?
| | Consumer Product Safety | 1 | 2013 | 80 | 0.090 |
Why?
| | Ovariectomy | 1 | 2012 | 165 | 0.090 |
Why?
| | Endometrial Neoplasms | 1 | 2013 | 205 | 0.080 |
Why?
| | Pressure | 1 | 2011 | 226 | 0.080 |
Why?
| | Aged, 80 and over | 3 | 2024 | 8318 | 0.080 |
Why?
| | Birth Weight | 1 | 2013 | 513 | 0.080 |
Why?
| | Rectovaginal Fistula | 1 | 2009 | 11 | 0.080 |
Why?
| | Rectal Diseases | 1 | 2009 | 24 | 0.080 |
Why?
| | Health Care Costs | 1 | 2013 | 425 | 0.070 |
Why?
| | Abscess | 1 | 2009 | 77 | 0.070 |
Why?
| | Pregnancy, Ectopic | 1 | 2009 | 54 | 0.070 |
Why?
| | Cicatrix | 1 | 2009 | 69 | 0.070 |
Why?
| | Early Detection of Cancer | 1 | 2013 | 482 | 0.070 |
Why?
| | Collagen | 2 | 2026 | 455 | 0.060 |
Why?
| | Smoking | 1 | 2013 | 1470 | 0.060 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2009 | 532 | 0.050 |
Why?
| | Reference Values | 1 | 2006 | 798 | 0.050 |
Why?
| | Genital Diseases, Female | 1 | 2005 | 31 | 0.050 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2024 | 16 | 0.050 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2004 | 27 | 0.050 |
Why?
| | Prostheses and Implants | 1 | 2005 | 137 | 0.050 |
Why?
| | Myofibroblasts | 1 | 2026 | 144 | 0.050 |
Why?
| | Urologic Surgical Procedures | 1 | 2005 | 115 | 0.050 |
Why?
| | Age Factors | 1 | 2012 | 3338 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2013 | 5411 | 0.050 |
Why?
| | Ultrasonography | 2 | 2021 | 784 | 0.050 |
Why?
| | Fibroblasts | 1 | 2009 | 1022 | 0.050 |
Why?
| | Estrogen Receptor beta | 1 | 2023 | 40 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2006 | 1546 | 0.050 |
Why?
| | Receptors, Androgen | 1 | 2023 | 148 | 0.040 |
Why?
| | Public Opinion | 1 | 2022 | 62 | 0.040 |
Why?
| | Pain Measurement | 1 | 2024 | 554 | 0.040 |
Why?
| | Cohort Studies | 2 | 2024 | 5988 | 0.040 |
Why?
| | Estrogen Receptor alpha | 1 | 2023 | 151 | 0.040 |
Why?
| | Pseudomonas aeruginosa | 1 | 2025 | 395 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2009 | 2504 | 0.040 |
Why?
| | Menopause | 1 | 2005 | 326 | 0.040 |
Why?
| | Infant, Newborn | 1 | 2013 | 6435 | 0.040 |
Why?
| | Mice | 5 | 2025 | 18303 | 0.040 |
Why?
| | Radiography, Abdominal | 1 | 2021 | 44 | 0.040 |
Why?
| | Estrogens | 1 | 2023 | 367 | 0.040 |
Why?
| | Postoperative Complications | 1 | 2012 | 2961 | 0.040 |
Why?
| | Child | 1 | 2019 | 22670 | 0.040 |
Why?
| | Neutrophils | 1 | 2024 | 1123 | 0.030 |
Why?
| | NIH 3T3 Cells | 2 | 2009 | 146 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2020 | 3616 | 0.030 |
Why?
| | Research Design | 1 | 2004 | 1132 | 0.030 |
Why?
| | Mice, Inbred C57BL | 3 | 2016 | 5972 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2023 | 873 | 0.030 |
Why?
| | Macrophages | 1 | 2024 | 1500 | 0.030 |
Why?
| | Connective Tissue | 1 | 2016 | 38 | 0.030 |
Why?
| | Animals | 5 | 2025 | 37952 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1145 | 0.030 |
Why?
| | Muscle, Smooth | 1 | 2016 | 153 | 0.030 |
Why?
| | Sensory Thresholds | 2 | 2005 | 31 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4538 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2024 | 17247 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1962 | 0.030 |
Why?
| | Device Approval | 1 | 2013 | 19 | 0.020 |
Why?
| | Decision Trees | 1 | 2013 | 78 | 0.020 |
Why?
| | Inflammation | 1 | 2024 | 2876 | 0.020 |
Why?
| | Gelatinases | 1 | 2012 | 6 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2928 | 0.020 |
Why?
| | Collagen Type III | 1 | 2012 | 15 | 0.020 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2012 | 12 | 0.020 |
Why?
| | Enzyme Precursors | 1 | 2012 | 15 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 26 | 0.020 |
Why?
| | Phenotype | 1 | 2020 | 3138 | 0.020 |
Why?
| | Nervous System Diseases | 2 | 2005 | 286 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2013 | 535 | 0.020 |
Why?
| | Collagen Type I | 1 | 2012 | 143 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 333 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 2524 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2013 | 640 | 0.020 |
Why?
| | Rectocele | 1 | 2009 | 4 | 0.020 |
Why?
| | Ischium | 1 | 2009 | 6 | 0.020 |
Why?
| | United States | 2 | 2021 | 16065 | 0.020 |
Why?
| | Uterine Artery Embolization | 1 | 2009 | 9 | 0.020 |
Why?
| | Abortifacient Agents, Nonsteroidal | 1 | 2009 | 20 | 0.020 |
Why?
| | Chorionic Gonadotropin | 1 | 2009 | 78 | 0.020 |
Why?
| | Pilot Projects | 2 | 2005 | 1889 | 0.020 |
Why?
| | Uterine Hemorrhage | 1 | 2009 | 41 | 0.020 |
Why?
| | Societies, Medical | 1 | 2013 | 898 | 0.020 |
Why?
| | Prolapse | 1 | 2008 | 6 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3892 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1995 | 0.020 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2008 | 55 | 0.020 |
Why?
| | Methotrexate | 1 | 2009 | 233 | 0.020 |
Why?
| | Self Report | 1 | 2012 | 867 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2008 | 130 | 0.020 |
Why?
| | Rats | 1 | 2016 | 5582 | 0.020 |
Why?
| | Polypropylenes | 1 | 2005 | 12 | 0.010 |
Why?
| | Anus Diseases | 1 | 2005 | 8 | 0.010 |
Why?
| | Touch | 1 | 2005 | 39 | 0.010 |
Why?
| | Nervous System | 1 | 2005 | 69 | 0.010 |
Why?
| | Anal Canal | 1 | 2005 | 102 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2013 | 1365 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1713 | 0.010 |
Why?
| | International Cooperation | 1 | 2004 | 197 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4142 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2004 | 739 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2008 | 2803 | 0.010 |
Why?
| | Comorbidity | 1 | 2005 | 1657 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2004 | 1579 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2005 | 1092 | 0.010 |
Why?
| | Male | 1 | 2013 | 72664 | 0.000 |
Why?
|
|
Guess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|